Observational SIR-Spheres Study for the Treatment of Unresectable Liver Tumors (SIRtain Registry)
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorSirtex Medical
About this trial
This registry seeks to prospectively gather a large repository of comprehensive observational data reflecting routine use of SIR-Spheres in patients diagnosed with unresectable HCC or unresectable liver metastases from mCRC refractory to or intolerant to chemotherapy, in order to assess clinical response in a real-world setting and further validate the safe and appropriate use of SIR-Spheres
Eligibility criteria
Qualifiers
Age 18 years or older
Unresectable hepatocellular carcinoma (HCC) Or
Unresectable liver metastases from colorectal cancer (mCRC) refractory to or intolerant to chemotherapy
Identified as a candidate for SIR-Spheres treatment as deemed appropriate during the normal course of practice
Disqualifiers
Prior radiation treatment to the liver
Patients participating in any interventional clinical trial with an investigational product, device, or procedure
Need for surrogate consent. Patients who are not able to consent on behalf of themselves are not eligible.
Trial design
Treatments tested in this trial
- SIRT
Treatment groups
845 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov